Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
Clinical trial NCT05216757 · UNKNOWN
Trial details
- NCT number
- NCT05216757
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.